You are here:
Home
NICE Guidance
NICE Advice
Evidence summaries
Chronic obstructive pulmonary disease: indacaterol/glycopyrronium (Ultibro Breezhaler)
Evidence summary
Reference number:
ESNM33
Published:
11 February 2014
Last updated:
04 March 2014
This evidence summary has been updated and replaced by
NICE guideline 115
.
Back to top